Evidence map›Paper›PMID 33841142›Full record

ArticleFrontiers in pharmacology2021

Polysaccharide Isolated From

Fang-Mei Zhou, Yu-Chi Chen, Chao-Ying Jin, Chao-Dong Qian, Bing-Qi Zhu, Ying Zhou, Zhi-Shan Ding, Yi-Qi Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Journal of microbiology and biotechnology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Research Progress on the Anticancer Activity of Plant Polysaccharides.Recent patents on anti-cancer drug discovery · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Antitumor effects of polysaccharides fromFrontiers in immunology · 2022
    Article
  12. Polysaccharides From the Aerial Parts ofFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fang-Mei ZhouCollege of Medical Technology, Zhejiang Chinese Medical University, Hangzhou, China.
Yu-Chi ChenCollege of Medical Technology, Zhejiang Chinese Medical University, Hangzhou, China.
Chao-Ying JinSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, China.
Chao-Dong QianCollege of Life Science, Zhejiang Chinese Medical University, Hangzhou, China.
Bing-Qi ZhuCollege of Medical Technology, Zhejiang Chinese Medical University, Hangzhou, China.
Ying ZhouDepartment of Cardiology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Zhi-Shan DingCollege of Medical Technology, Zhejiang Chinese Medical University, Hangzhou, China.
Yi-Qi WangSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, China.
Zhejiang Chinese Medical University · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvantantitumorpolysaccharideRAW264.7Tetrastigma hemsleyanumTHP-1TLR4

Identifiers

PMID33841142
PMCPMC8024652
OpenAlexW3137218769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.